Early cognitive development in children with infantile Pompe disease

Molecular Genetics and Metabolism

Volumn 105, Issue 3, 2012, Pages 428-432

  Spiridigliozzi, Gail A ^a   Heller, James H ^a   Case, Laura E ^a   Jones, Harrison N ^a   Kishnani, Priya S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cognitive development; Enzyme replacement therapy; Infantile Pompe disease; Motor development; Phenotype

Indexed keywords

RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE;

ARTICLE; CHILD DEVELOPMENT; CHILD PSYCHOLOGY; CLINICAL ARTICLE; COGNITION; COGNITIVE DEVELOPMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME REPLACEMENT; GESTATIONAL AGE; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; INFANT; MENTAL DEVELOPMENT; MENTAL DEVELOPMENT INDEX; MOTOR DEVELOPMENT; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SURVIVOR; TREATMENT DURATION; TREATMENT RESPONSE;

ALPHA-GLUCOSIDASES; COGNITION; COHORT STUDIES; ENZYME REPLACEMENT THERAPY; FEMALE; GLYCOGEN; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOTOR SKILLS;

EID: 84858282638     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.10.012     Document Type: Article

References (17)

1. Prater S., Banugaria S., Young S., DeArmey S., Botha E., Stege E., Case L., Jones H., Phornphutkul C., Wang R., Kishnani P. The emerging phenotype of long-term survivors with infantile pompe disease. Personal communication 2011.
2. Jones H., Muller C., Lin M., Banugaria S., Case L., Li J., O'Grady G., Heller J., Kishnani P. Oropharyngeal Dysphagia in Infants and Children with Infantile Pompe Disease. Dysphagia 2010, 25:277-283.
3. Muller C., Jones H., O'Grady G., Suzrez A., Heller J., Kishnani P. Language and speech function in children with infantile Pompe disease. Journal of Pediatric Neurology 2009, 7:147-156.
4. Teng Y., Su W., Hou J., Huang S. Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings. Chang Gung Medical Journal 2004, 27:379-384.
5. Martin J., de Barsy T., Van Hoof F., Palladini G. Pompe's disease: an inborn lysosomal disorder with storage of glycogen. Acta neuropathology 1973, 23:229-244.
6. Martini C., Ciana G., Benettoni A., Katouzian F., Severini G., Bussani R., Bembi B. Intractable fever and cortical neuronal glycogen storage in glycogenosis type 2. Neurology 2001, 57:906-908.
7. Chen C.-P., Lin S.-P., Tzen C.-Y., Tsai F.-J., Hwu W.-L., Wang W. Detection of a homozygous D645E mutation of the acid α-glucosidase gene and glycogen deposition in tissues in a second-trimester fetus with infantile glycogen storage disease type II. Prenatal Diagnosis 2004, 24:231-232.
8. Chien Y., Lee N., Peng S., Hwu W. Brain development in infantile-onset pompe disease treated by enzyme replacement therapy. Pediatric Research 2006, 60:349-352.
9. Sidman R., Taksir T., Fidler J., Zhao M., Dodge J., Passini M., Raben N., Thurberg B., Cheng S., Shihabuddin L. Temporal neuropathologic and behavioral phenotype of 6neo/6neo pompe disease mice. Journal of Neuropathology and Experimental Neurology 2008, 8:803-818.
10. Kishnani P., Corzo D., Nicolino M., Byrne B., Mandel H., Hwu W., Leslie N., Levine J., Spencer C., McDonald M., Li J., Dumontier J., Halberthal M., Chien Y., Hopkin R., Vijayaraghavan S., Gruskin D., Bartholomew D., van der Ploeg A., Clancy J., Parini R., Morin G., Beck M., De la Gastine G., Jokic M., Thurberg B., Richards S., Bali D., Davison M., Worden M., Chen Y., Wraith J. Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 2007, 68:99-109.
11. Bayley N. Bayley Scales of Infant Development 1993, The Psychological Corporation, San Antonio, Texas.
12. Piper M., Darrah J. Motor Assessment of the Developing Infant 1994, WB Saunders Co, Philadelphia, PA.
13. Chaudhari S., Bhalerao M., Chitale A., Pandit A., Nene U. Pure low birth weight study - a six year follow up. Indian Pediatrics 1993, 36:669-676.
14. Holditch-Davis D., Docherty S., Miles M.S., Burchinal M. Developmental outcomes of infants with bronchopulmonary dysplasia: Comparison with other medically fragile infants. Research in Nursing & Health 2001, 24:181-193.
15. Wray J., Radley-Smith R. Cognitive and behavioral functioning of children listed for heart and/or lung transplantation. American Journal of Transplantation 2010, 10:2527-2535.
16. Taras H., Potts-Datema W. Chronic health conditions and student performance at school. Journal of School Health 2005, 75:255-266.
17. Rohrbach M., Klein A., Kohli-Wiesner A., Veraguth D., Scheer I., Balmer C., Lauener R., Baumgartner M.R. CRIM-negative infantile Pompe disease: 42-month treatment outcome. Journal of Inherited Metabolic Disease 2010, 33:751-757.